日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aflibercept vs ranibizumab biosimilars: manufacturing differences that might matter in the long run

阿柏西普与雷珠单抗生物类似药:生产工艺差异可能在长期内产生影响

Sharma, Ashish; Bandello, Francesco; Bandyopadhyay, Sanjay; Kumar, Nilesh; Parachuri, Nikulaa

Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study

生物类似药雷珠单抗(Ranieyes)在真实世界中的安全性和有效性:BRESER 研究

Sharma, Ashish; Holz, Frank G; Kumar, Nilesh; Sarraf, David; Ayachit, Seemantini; Mishra, Chitaranjan; Tufail, Adnan; Chakraborty, Debdulal; Rachitskaya, Aleksandra; Eichenbaum, David; Banker, Alay; Parachuri, Nikulaa; Kumar, Ashish; Loewenstein, Anat; Bandello, Francesco; Wakabayashi, Taku; Woo, Se Joon; Kuppermann, Baruch D

Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally

阿柏西普 2 毫克生物类似药——它们能否在全球抗 VEGF 生物类似药领域引领潮流?

Sharma, Ashish; Woo, Se Joon; Lee, Christopher Seungkyu; Kumar, Nilesh; Parachuri, Nikulaa; Bandello, Francesco; Loewenstein, Anat; Kuppermann, Baruch D

Aflibercept biosimilars - update on the development progress

阿柏西普生物类似药——研发进展最新情况

Sharma, Ashish; Loewenstein, Anat; Kumar, Nilesh; Parachuri, Nikulaa; Bandello, Francesco; Kuppermann, Baruch D

Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)

由国际视网膜生物类似药研究组(Inter-BIOS Group)与印度玻璃体视网膜学会(VRSI)合作开展的《2023 年印度抗 VEGF 视网膜疾病生物类似药调查》(Bio-INDAS)

Sharma, Ashish; Kaiser, Peter K; Tadayoni, Ramin; Holz, Frank G; Nicholson, Luke; Vazquez-Alfageme, Clara; Sivaprasad, Sobha; Wakabayashi, Taku; Woo, Se Joon; Sarraf, David; Kumar, Nilesh; Parachuri, Nikulaa; Regillo, Carl D; Rezaei, Kourous A; Khanani, Arshad M; Bandello, Francesco; Shanamugam, Mahesh; Verma, Lalit; Dogra, Mangat Ram; Ns, Muralidhar; Agarwal, Manisha; Loewenstein, Anat; Kuppermann, Baruch D

Understanding Retinal Vasculitis Associated with Brolucizumab: Complex Pathophysiology or Occam's Razor?

了解与 Brolucizumab 相关的视网膜血管炎:复杂的病理生理机制还是奥卡姆剃刀原理?

Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Singh, Sonali; Bandello, Francesco; Regillo, Carl D; Boyer, David; Nguyen, Quan Dong

Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India

补充营养对视网膜健康的影响:印度市售制剂的循证分析

Sharma, Ashish; Kumar, Nilesh; Parachuri, Nikulaa; Kuppermann, Baruch D; Bandello, Francesco

Ranizurel safety evaluation in real-world -(RaSER) study

雷尼唑胺真实世界安全性评估(RaSER)研究

Sharma, Ashish; Arunaprakash, Jayshree; Das, Atheeshwar; Nayaka, Ashraya; Kumar, Nilesh; Parachuri, Nikulaa; Kuppermann, Baruch D

Commentary: Acute central serous chorioretinopathy - Treat early, observe longer

评论:急性中心性浆液性脉络膜视网膜病变——早期治疗,长期观察

Kumar, Nilesh; Parachuri, Nikulaa; Sharma, Ashish